Dr. Mel Chua: Evolution of ChemoRT Trials in Nasopharyngeal Carcinoma: A Hobbit's Journey Part
1 vistas
• 07/12/23
0
0
Empotrar
administrator
Suscriptores
In this second part of his lecture, Dr. Chua discusses ongoing trials in NPC, the significance of EBV titers and implications of the EBV vaccine, and his recently published trial in oligometastic NPC, among other topics.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios